Semaglutide.
The most studied GLP-1 therapy for weight management — once weekly, clinician guided.
Semaglutide targets the GLP-1 receptor to reduce appetite, slow gastric emptying, and support blood sugar regulation. When paired with healthy lifestyle changes, it may support meaningful, sustained weight loss.
The most studied path to lasting change.
Reduces appetite & cravings
Targets the GLP-1 receptor to curb hunger between meals.
Average ~14.9% weight loss
Per STEP-1 clinical trial at the highest tolerated dose.
Once-weekly injection
A simple routine administered at home.
Decade-long safety record
The most prescribed GLP-1 worldwide, backed by years of data.
Delivered overnight
Cold-chain shipping included in every plan.
Unlimited messaging
Questions answered whenever you need support.
Results worth talking about.
In the STEP-1 trial, adults taking semaglutide saw meaningful, sustained changes — progress that holds up over time.
STEP-1 (N=1,961). Results shown represent the highest tolerated dose. Individual outcomes vary. Wilding JPH et al. NEJM 2021.
One simple price. Less the longer you stay.
Every plan includes the medication, your clinician, and free overnight shipping. Cancel anytime.
- ✓ Medication
- ✓ Clinical review
- ✓ Unlimited clinician messaging
- ✓ Free overnight shipping
- ✓ Cancel anytime
No charge until a clinician approves your plan.
From assessment to first dose in under a week.
Complete Intake
Brief questionnaire and medical history.
Clinical Review
Licensed clinician evaluates eligibility.
Treatment Delivered
Medication shipped to your door.
Continued Care
Messaging and adjustments as needed.